BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 17548670)

  • 1. Genetic variation in H2AFX contributes to risk of non-Hodgkin lymphoma.
    Novik KL; Spinelli JJ; Macarthur AC; Shumansky K; Sipahimalani P; Leach S; Lai A; Connors JM; Gascoyne RD; Gallagher RP; Brooks-Wilson AR
    Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1098-106. PubMed ID: 17548670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex- and subtype-specific analysis of H2AFX polymorphisms in non-Hodgkin lymphoma.
    Bretherick KL; Schuetz JM; Morton LM; Purdue MP; Conde L; Gallagher RP; Connors JM; Gascoyne RD; Berry BR; Armstrong B; Kricker A; Vajdic CM; Grulich A; Hjalgrim H; Smedby KE; Skibola CF; Rothman N; Spinelli JJ; Brooks-Wilson AR
    PLoS One; 2013; 8(9):e74619. PubMed ID: 24069324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. H2AFX polymorphisms are associated with decreased risk of diffuse large B cell lymphoma in Koreans.
    Jin XM; Kim HN; Shin MH; Lee IK; Lee JS; Lee JH; Kim HJ; Choi JS; Juhng SW; Choi C
    DNA Cell Biol; 2011 Dec; 30(12):1039-44. PubMed ID: 21631283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphoma.
    Cerhan JR; Liu-Mares W; Fredericksen ZS; Novak AJ; Cunningham JM; Kay NE; Dogan A; Liebow M; Wang AH; Call TG; Habermann TM; Ansell SM; Slager SL
    Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3161-9. PubMed ID: 18990758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variants in ATM, H2AFX and MRE11 genes and susceptibility to breast cancer in the polish population.
    Podralska M; Ziółkowska-Suchanek I; Żurawek M; Dzikiewicz-Krawczyk A; Słomski R; Nowak J; Stembalska A; Pesz K; Mosor M
    BMC Cancer; 2018 Apr; 18(1):452. PubMed ID: 29678143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune mechanisms in non-Hodgkin lymphoma: joint effects of the TNF G308A and IL10 T3575A polymorphisms with non-Hodgkin lymphoma risk factors.
    Wang SS; Cozen W; Cerhan JR; Colt JS; Morton LM; Engels EA; Davis S; Severson RK; Rothman N; Chanock SJ; Hartge P
    Cancer Res; 2007 May; 67(10):5042-54. PubMed ID: 17510437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms in DNA repair genes, hair dye use, and the risk of non-Hodgkin lymphoma.
    Guo H; Bassig BA; Lan Q; Zhu Y; Zhang Y; Holford TR; Leaderer B; Boyle P; Qin Q; Zhu C; Li N; Rothman N; Zheng T
    Cancer Causes Control; 2014 Oct; 25(10):1261-70. PubMed ID: 25178586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common gene variants in the tumor necrosis factor (TNF) and TNF receptor superfamilies and NF-kB transcription factors and non-Hodgkin lymphoma risk.
    Wang SS; Purdue MP; Cerhan JR; Zheng T; Menashe I; Armstrong BK; Lan Q; Hartge P; Kricker A; Zhang Y; Morton LM; Vajdic CM; Holford TR; Severson RK; Grulich A; Leaderer BP; Davis S; Cozen W; Yeager M; Chanock SJ; Chatterjee N; Rothman N
    PLoS One; 2009; 4(4):e5360. PubMed ID: 19390683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of non-Hodgkin lymphoma associated with germline variation in genes that regulate the cell cycle, apoptosis, and lymphocyte development.
    Morton LM; Purdue MP; Zheng T; Wang SS; Armstrong B; Zhang Y; Menashe I; Chatterjee N; Davis S; Lan Q; Vajdic CM; Severson RK; Holford TR; Kricker A; Cerhan JR; Leaderer B; Grulich A; Yeager M; Cozen W; Hoar Zahm S; Chanock SJ; Rothman N; Hartge P
    Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1259-70. PubMed ID: 19336552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variations in chromosomes 9 and 6p21.3 with risk of non-Hodgkin lymphoma.
    Wang SS; Menashe I; Cerhan JR; Cozen W; Severson RK; Davis S; Hutchinson A; Rothman N; Chanock SJ; Bernstein L; Hartge P; Morton LM
    Cancer Epidemiol Biomarkers Prev; 2011 Jan; 20(1):42-9. PubMed ID: 21148756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms in oxidative stress genes and risk for non-Hodgkin lymphoma.
    Wang SS; Davis S; Cerhan JR; Hartge P; Severson RK; Cozen W; Lan Q; Welch R; Chanock SJ; Rothman N
    Carcinogenesis; 2006 Sep; 27(9):1828-34. PubMed ID: 16543247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C677T and A1298C polymorphisms of methylene tetrahydrofolate reductase in non-Hodgkin lymphoma: southeast Iran.
    Mashhadi MA; Miri-Moghaddam E; Arbabi N; Bazi A; Heidari Z; Sepehri Z; Karimkoshte A; Rezvan A; Hashemi SM
    Tumori; 2018 Aug; 104(4):280-284. PubMed ID: 28430351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms in ghrelin and neuropeptide Y genes are associated with non-Hodgkin lymphoma.
    Skibola DR; Smith MT; Bracci PM; Hubbard AE; Agana L; Chi S; Holly EA
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1251-6. PubMed ID: 15894681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common genetic variants in proinflammatory and other immunoregulatory genes and risk for non-Hodgkin lymphoma.
    Wang SS; Cerhan JR; Hartge P; Davis S; Cozen W; Severson RK; Chatterjee N; Yeager M; Chanock SJ; Rothman N
    Cancer Res; 2006 Oct; 66(19):9771-80. PubMed ID: 17018637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms in DNA repair genes and risk of non-Hodgkin's lymphoma in New South Wales, Australia.
    Shen M; Purdue MP; Kricker A; Lan Q; Grulich AE; Vajdic CM; Turner J; Whitby D; Chanock S; Rothman N; Armstrong BK
    Haematologica; 2007 Sep; 92(9):1180-5. PubMed ID: 17666372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible association between genetic variants in the H2AFX promoter region and risk of adult glioma in a Chinese Han population.
    Fan W; Zhou K; Zhao Y; Wu W; Chen H; Jin L; Chen G; Shi J; Wei Q; Zhang T; Du G; Mao Y; Lu D; Zhou L
    J Neurooncol; 2011 Nov; 105(2):211-8. PubMed ID: 21512825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms in pattern-recognition genes in the innate immunity system and risk of non-Hodgkin lymphoma.
    Hu W; Bassig BA; Xu J; Zheng T; Zhang Y; Berndt SI; Holford TR; Hosgood HD; Leaderer B; Yeager M; Menashe I; Boyle P; Zou K; Zhu Y; Chanock S; Lan Q; Rothman N
    Environ Mol Mutagen; 2013 Jan; 54(1):72-7. PubMed ID: 23055202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-X-C chemokine receptor type 5 gene polymorphisms are associated with non-Hodgkin lymphoma.
    Song H; Tong D; Cha Z; Bai J
    Mol Biol Rep; 2012 Sep; 39(9):8629-35. PubMed ID: 22707196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Association of gene polymorphisms in the DNA repair gene XPD with risk of non-Hodgkin's lymphoma].
    Song B; Zhu JY; Liu J; Wang ZH; Shi Y; Lü LY; Zheng Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):97-100. PubMed ID: 18315909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variation in the NBS1, MRE11, RAD50 and BLM genes and susceptibility to non-Hodgkin lymphoma.
    Schuetz JM; MaCarthur AC; Leach S; Lai AS; Gallagher RP; Connors JM; Gascoyne RD; Spinelli JJ; Brooks-Wilson AR
    BMC Med Genet; 2009 Nov; 10():117. PubMed ID: 19917125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.